Form 4: Cytek Biosciences CEO Wenbin Jiang Disposes of 200,000 Shares as Gift
SEC Form 4 Filing
Cytek Biosciences' CEO, Wenbin Jiang, reported the disposition of 200,000 shares of common stock as a gift on September 14, 2024, while still holding a substantial number of shares.
Summary
- On September 14, 2024, Wenbin Jiang, the President and CEO of Cytek Biosciences, disposed of 200,000 shares of common stock.
- The transaction was classified as a gift, with a price of $0 per share.
- Following the transaction, Jiang directly owns 5,156,896 shares of Cytek Biosciences.
- The transaction was reported on a Form 4 filing with the SEC on September 16, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a stock transaction. The gift of shares itself doesn't necessarily indicate positive or negative sentiment, but the CEO still holds a significant amount of shares.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Gifts of stock are not uncommon for estate planning or charitable purposes.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it involves a change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 09/14/2024 | Date of the transaction (disposal of shares) |
| 09/16/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.